Validation of EORTC Prognostic Factors for Adults With Low-Grade Glioma: A Report Using Intergroup 86-72-51
T.B. Daniels, Edward G. Shaw(Wake Forest University), Ross A. Abrams(Rush University Medical Center), David Schiff(University of Virginia), Walter J. Curran(Piedmont Cancer Institute), Wenting Wu(East China Normal University), Paul D. Brown(Mayo Clinic), Sara J. Felten(Mayo Clinic), Jan C. Buckner(McGill University), Robert M. Arusell(Mayo Clinic)
Cited by 137
Related Papers
A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
|New England Journal of Medicine|2014|2.8k
Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial
|The Lancet|2004|2.4k
Summary Report on the Graded Prognostic Assessment: An Accurate and Facile Diagnosis-Specific Tool to Estimate Survival for Patients With Brain Metastases
|Journal of Clinical Oncology|2011|1.4k
Phase III Trial of Chemoradiotherapy for Anaplastic Oligodendroglioma: Long-Term Results of RTOG 9402
|Journal of Clinical Oncology|2012|1.2k